Showing results (231-240 of 266) with videos related to

Sort By:
Pageof 27
Methods (San Diego, Calif.)|April 3, 2021
The performance of human cytomegalovirus digital PCR reference measurement procedure in seven external quality assessment schemes over four yearsMojca Milavec, Jernej Pavšič, Alexandra Bogožalec Košir, et al.
European Urology|July 27, 2019
Prostate-specific Membrane Antigen Heterogeneity and DNA Repair Defects in Prostate CancerAlec Paschalis, Beshara Sheehan, Ruth Riisnaes, et al.
European Urology|March 8, 2021
CD38 in Advanced Prostate CancersChristina Guo, Mateus Crespo, Bora Gurel, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 31, 2023
Development and Validation of a New BAG-1L-Specific Antibody to Quantify BAG-1L Protein Expression in Advanced Prostate CancerAntje Neeb, Ines Figueiredo, Bora Gurel, et al.
Cancer Research Communications|July 31, 2023
Identification of an Imidazopyridine-based Compound as an Oral Selective Estrogen Receptor Degrader for Breast Cancer TherapyMengwu Pan, Valeria Solozobova, Nane C Kuznik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2021
Emergence of Enzalutamide Resistance in Prostate Cancer is Associated with BCL-2 and IKKB DependenciesYi Liang, Sujeeve Jeganathan, Stefano Marastoni, et al.
The Journal of Clinical Investigation|October 19, 2018
Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancerAdam Sharp, Ilsa Coleman, Wei Yuan, et al.
The Journal of Clinical Investigation|April 1, 2026
Androgen receptor splice variant 7 expression levels distinguish AR-mutated from nonmutated metastatic castration-resistant prostate cancersAlec Paschalis, Ines Figueiredo, Denisa Bogdan, et al.
European Urology Oncology|March 12, 2026
An Open-label, Phase 1 Dose-finding Study of Single-agent IMU-935, a Novel RORγ/RORγt Inverse Agonist, in Patients with Progressive Metastatic Castration-resistant Prostate CancerRafael Grochot, Christina Guo, Suzanne Carreira, et al.
Nature|June 29, 2018
IL-23 secreted by myeloid cells drives castration-resistant prostate cancerArianna Calcinotto, Clarissa Spataro, Elena Zagato, et al.
Pageof 27